The natural history of squamous cancer of the uterine cervix resembles that of a sexually transmitted disease (Kessler II, 1976) . Potential aetiological agents include the transforming members of the human papillomaviruses, in particular HPV types 16 and 18, since a high proportion of patients with cervical intraepithelial neoplasia (CIN) and invasive carcinoma of the cervix are infected with these HPV types (zur Hausen, 1987; Cornelisson et al., 1989). In contrast, the prevalence of HPV 16 based on rigorous polymerase chain reaction (PCR) studies in women with no evidence of cervical disease is between 5-17% (Van den Brule et al., Bavin et al., 1992) . Complementary to the epidemiological investigations linking HPV 16 and cervical cancer, in vitro studies have shown that HPV 16 is capable of immortalising transformed cell lines through the E6 and E7 protein products binding to the cellular tumour suppressor genes p53 and plO5RB respectively (Dyson et al., 1989; . Recent data (Crook et al., 1992) have shown that in women with cervical carcinoma, mutations in p53 and the presence of HPV 16 or 18 DNA are mutually exclusive, thus confirming similar data obtained from analysis of established cervical cancer cell lines (Crook et al., 1991; .
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In addition to a possible role in the aetiology of cervical carcinoma, the presence of HPV 16 DNA may be of use as a prognostic marker of high-grade cervical disease, i.e. CIN 2 and CIN 3. Previous work in our laboratory (Bavin et al., 1992) has shown that the presence of HPV 16 DNA is useful in identifying women with high-grade cervical disease within a general practice population with an associated relative risk of 5.67. In addition, the combination of cytology and HPV 16 positivity identified more women with significant disease than either screening method alone. However, the clinical setting which would most benefit from a prognostic marker of high-grade cervical disease is in the large number of women referred for colposcopy with a smear suggesting mild dyskaryosis. We have previously shown (Giles et al., 1989 ) that approximately one third of these women will have high-grade disease whilst the remainder will have either CIN 1 or be colposcopically normal. A mechanism to differentiate women with high-grade disease within such a referral population would have a significant impact on targeting colposcopic resources to those individuals at high risk.
Recent use of a semi-quantitative PCR method (Cuzick et al., 1992) has suggested that the presence of high or intermediate quantities of HPV 16 DNA in cervical scrapes is useful in identifying women with high-grade cervical disease within populations referred with a mild or moderately dyskaryotic smear. However, it should be noted that the data provided for the population referred with a mildly dyskaryotic smear contained relatively small numbers of women (23 in total). Therefore, we report here the qualitative and semi-quantitative PCR assessment of HPV 16 DNA in a population of 200 women referred with a smear suggesting mild dyskaryosis. We reasoned that such analyses on such a large cohort should enable a critical evaluation of the whether the mere presence or, as suggested by Cuzick and coworkers, the amount of HPV 16 DNA is a useful marker of high-grade cervical disease in such populations.
Subjects and methods
The study group was composed of 200 patients sequentially attending the Royal Free Hospital colposcopy clinic, referred with a smear report suggesting mild dyskaryosis. The clinical details of this population have been described elsewhere (Giles et al., 1989) . Following colposcopy and histopathology of directed biopsies when appropriate, a final diagnosis was made in 179 women. Of these, 54 had no evidence of cervical disease, 14 had evidence of wart virus infection, 45 had CIN 1, 31 had CIN 2 and 35 had CIN 3. The mean age for the population was 29 years (mean age of women with CIN: 26.9 years; mean age of women with no evidence of cervical abnormality: 33.5 years).
Two cervical scrapes were taken from each patient; one for standard cytological analysis and the second placed in 10 ml of cold phosphate buffered saline. The cells from the latter sample were harvested by centrifugation and the DNA extracted with SDS-Proteinase K lysis and purified by phenol/ chloroform extraction and ethanol precipitation. PCR was performed using a Hybaid Thermal Reactor (HBTR1) as described previously (Bavin et al., 1992 Table IV . The sensitivity of detecting women with high-grade cervical disease is increased when both criteria are used (0.89 vs 0.58) without affecting specificity (0.73 vs 0.76). Likewise, the negative predictive value associated with using both criteria is significantly increased (0.89 vs 0.74).
Discussion
W^e have assessed whether HPV 16 DNA can be a useful discriminator to identify women with high-grade disease (CIN 2/CIN 3) in a group referred to a colposcopy clinic with a smear suggesting mild dyskaryosis. The primary analysis revealed that the qualitative detection of HPV 16 found by Schneider and colleages (54%; Scneider et al., 1987) . The high prevalence of HPV 16 in the apparently normal group impairs the ability of qualitative assays for HPV 16 to identify women with current high-grade disease.
On the basis of recent data suggesting that high or intermediate levels of HPV 16 DNA may be useful to idenitify women with high-grade disease, our population was re-examined using the semi-quantitative methods described by Cuzick and colleagues (1992) . The results clearly demonstrated that a high/medium quantity of HPV 16 DNA is significantly associated with high-grade cervical disease whilst women with either CIN 1 or who are normal are more likely to be HPV 16 DNA low or negative (P = 0.0001). It is interesting to note that the proportion of women with high-grade disease who possessed high/medium levels of HPV 16 DNA was similar to that previously reported (Cuzick et al., 1992) , in which relatively small numbers of women were available for analysis. The major effect of using the discriminator of high/medium quantities of HPV 16 DNA is to reduce the number of women identified within the group who have a final diagnosis of CIN I/WVI/normal rather than increase the detection of women with high-grade disease.
We have previously shown that, in a general practice setting, the combination of cytology and qualitative presence of HPV 16 DNA identified more women with high-grade disease than either test alone (Bavin et al., 1992) . Current management of women referred with a smear suggesting mild dyskaryosis involves a repeat smear analysis at the time of colposcopy. One system for patient management would be to perform semi-quantitative PCR for HPV 16 and cytology on this specimen and only colposcope those women with either smears suggesting high-grade disease and/or high levels of HPV 16 DNA. In our study population, 155/179 women had a satisfactory repeat smear and the combination of repeat cytology and/or of HPV 16 DNA resulted in the identification of 89% of women with a final diagnosis of CIN 2/CIN 3. Furthermore, only one of the 60 women with high-grade disease would have been returned to routine follow-up. As expected, the combination of assays resulted in 28.5% of women with CIN l/WVI/normal being classified as requiring rapid colposcopic examination. However, the combination of repeat cytology 6 months after the original smear suggesting mild dyskaryosis and quantitative assessment of HPV 16 DNA would result in a 49% decrease in the number of women referred for colposcopy. Such an approach would enable colposcopic resources to be targeted at women most at risk of having high-grade disease without compromising the detection rate for high-grade disease.
In conclusion, our data confirm and extend those reported by Cuzick et al. (1992) , and indicate the effectiveness of a combination of repeat cytology and semi-quantitative PCR in identifying women with high-grade disease within the female population referred with a smear suggesting mild dyskaryosis. We are currently applying more sophisticated methods for PCR quantification (Fox et al., 1992) to fully investigate the levels of HPV 16 DNA present in cervical scrapes and its correlation with future development of cervical disease.
